Cellular and molecular mechanisms of opioid action

Progress in Brain Research

Volumn 129, Issue , 2000, Pages 483-492

  Ingram, Susan L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; CYCLOOXYGENASE 1 INHIBITOR; MORPHINE; NEUROTRANSMITTER; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; POTASSIUM CHANNEL;

4 AMINOBUTYRIC ACID RELEASE; ADAPTATION; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; DRUG DEPENDENCE; DRUG TOLERANCE; HYPERALGESIA; MOLECULAR MECHANICS; NERVE CELL PLASTICITY; NERVE INJURY; NEUROTRANSMITTER RELEASE; NOCICEPTION; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; SENSITIZATION; VENTRAL TEGMENTUM;

EID: 0034589048     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(00)29035-3     Document Type: Article

References (77)

1. Akil, H., Owens, C., Gutstein, H., Taylor, L., Curran, E. and Watson, S. (1998) Endogenous opioids: Overview and current issues. Drug Alcohol Depend., 51: 127-140.
2. Atweh, S.F. and Kuhar, M.J. (1977) Autoradiographic localization of opiate receptors in rat brain, II. The brain stem. Brain Res., 129: 1-12.
3. Avidor-Reiss, T., Nevo, I., Saya, D., Bayewitch, M. and Vogel, Z. (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J. Biol. Chem., 272: 5040-5047.
4. Bandler, R. and Shipley, M.T. (1994) Columnar organization in the midbrain periaqueductal gray: Modules for emotional expression?. Trends Neurosci., 17: 379-389.
5. Basbaum, A.I. and Fields, H.L. (1978) Endogenous pain control mechanisms: Review and hypothesis. Ann. Neurol., 4: 451-462.
6. Basbaum, A.I. and Fields, H.L. (1984) Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci., 7: 309-338.
7. Behbehani, M.M. and Fields, H.L. (1979) Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia. Brain Res., 170: 85-93.
8. Behbehani, M.M., Jiang, M. and Chandler, S.D. (1990) The effect of [MET]enkephalin on the periaqueductal gray neurons of the rat: An in vitro study. Neuroscience, 38: 373-380.
9. Bjorkman, R.L., Hedner, T., Hallman, K.M., Henning, M. and Hedner, J. (1992) Localization of the central antinociceptive effects of diclofenac in the rat. Brain Res., 590: 66-73.
10. h in central neurons. Neuron, 2: 1535-1540.
11. Bonci, A. and Williams, J.T. (1996) A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron, 16: 631-639.
12. Bonci, A. and Williams, J.T. (1997) Increased probability of GABA release links adenylyl cyclase and chronic morphine treatment. J. Neurosci., 17: 796-803.
13. Brown, H. and DiFrancesco, D. (1980) Voltage-clamp investigations of membrane currents underlying pace-make activity in rabbit sino-atrial node. J. Physiol. (Lond.), 308: 331-351.
14. Cannon, J.T., Prieto, G.J., Lee, A. and Liebeskind, J.C. (1982) Evidence for opioid and non-opioid forms of stimulation-produced analgesia in the rat. Brain Res., 243: 315-321.
15. Capogna, M., Gähwiler, B.H. and Thompson, S.M. (1993) Mechanism of μ-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J. Physiol. (Lond.), 470: 539- 558.
16. Chieng, B. and Christie, M.J. (1994a) Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br. J. Pharmacol., 113: 121-128.
17. Chieng, B. and Christie, M.J. (1994b) Inhibition by opioids acting on μ-receptors of GABAergic and glutamatergic post-synaptic potentials in single rat periaqueductal gray neurones in vitro. Br. J. Pharmacol., 113: 303-309.
18. Chieng, B. and Williams, J.T. (1998) Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal. J. Neurosci., 18: 7033-7039.
19. Christie, M.J., Williams, J.T., Osborne, P.B. and Bellchambers, C.E. (1997) Where is the locus in opioid withdrawal?. Trends Pharmacol. Sci., 18: 134-140.
20. Christie, M.J., Vaughan, C.W. and Ingram, S.L. (1999) Opioids, NSAIDs and 5-lipoxygenase inhibitors act synergistically in brain via arachidonic acid metabolism. Inflamm. Res., 48: 1-4.
21. Cohen, G.A., Doze, V.A. and Madison, D.V. (1992) Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron, 9: 325-335.
22. Collier, H.O. and Francis, D.L. (1975) Morphine abstinence is associated with increased brain cyclic AMP. Nature, 255: 159- 162.
23. 2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J. Physiol. (Lond.), 509: 47-58.
24. Dahl, J.B. and Kehlet, H. (1991) Non-steroidal anti-inflammatory drugs: Rationale for use in severe postoperative pain. Br. J. Anaesth., 66: 703-712.
25. Dellemijn, P. (1999) Are opioids effective in relieving neuropathic pain?. Pain, 80: 453-462.
26. Depaulis, A., Morgan, M.M. and Liebeskind, J.C. (1987) GABAergic modulation of the analgesic effects of morphine microinjected in the ventral periaqueductal gray matter of the rat. Brain Res., 436: 223-228.
27. Duggan, A.W. and North, R.A. (1984) Electrophysiology of opioids. Pharmacol. Rev., 35: 219-281.
28. Fields, H.L., Vanegas, H., Hentall, I.D. and Zorman, G. (1983) Evidence that disinhibition of brain stem neurones contributes to morphine analgesia. Nature, 306: 684-686.
29. Fields, H.L., Barbaro, N.M. and Heinricher, M.M. (1988) Brain stem neuronal circuitry underlying the antinociceptive action of opiates. In: H.L. Fields and J.-M. Besson (Eds.), Pain Modulation. Progress in Brain Research, Vol. 77. Elsevier, Amsterdam, pp. 245-257.
30. Fry, J.P., Herz, A. and Zieglgänsberger, W. (1980) A demonstration of naloxone-precipitated opiate withdrawal on single neurones in the morphine-tolerant dependent rat brain. Br. J. Pharmacol., 68: 585-592.
31. Fukuda, K., Kato, S., Morikawa, H., Shoda, T. and Mori, K. (1996) Functional coupling of the δ-, μ-, and κ-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J. Neurochem., 67: 1309-1316.
32. Gebhart, G.F. and Toleikis, J.R. (1978) An evaluation of stimulation-produced analgesia in the cat. Exp. Neurol., 62: 570-579.
33. Gross, R.A. and Macdonald, R.L. (1987) Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture. Proc. Natl. Acad. Sci. USA, 84: 5469-5473.
34. Grudt, T.J. and Williams, J.T. (1995) Opioid receptors and the regulation of ion conductances. Rev. Neurosci., 6: 279-286.
35. Hurley, R.W. and Hammond, D.L. (2000) The analgesic effects of supraspinal μ and delta opioid receptor agonists are potentiated during persistent inflammation. J. Neurosci., 20: 1249-1259.
36. h via adenylyl cyclase. Neuron, 13: 179-186.
37. Ingram, S.L., Vaughan, C.W., Bagley, E.E., Connor, M. and Christie, M.J. (1998) Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J. Neurosci., 18: 10269-10276.
38. Ito, S., Okuda-Ashitaka, E., Imanishi, T. and Minami, T. (2000) Central roles of nociceptin/orphanin FQ and nocistatin: Allodynia as a model of neural plasticity. In: J. Sandkühler, B. Bromm and G.F. Gebhart (Eds.), Nervous System Plasticity and Chronic Pain. Progress in Brain Research, Vol. 129. Elsevier, Amsterdam, pp. 205-218.
39. Johnson, S.M. and Duggan, A.W. (1981) Evidence that the opiate receptors of the substantia gelatinosa contribute to the depression, by intravenous morphine, of the spinal transmission of impulses in unmyelinated primary afferents. Brain Res., 207: 223-228.
40. Johnson, S.W. and North, R.A. (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci., 12: 483-488.
41. 2+ channels in the rat periaqueductal gray neurons by μ-type opioid agonist. J. Neurophysiol., 77: 1418-1424.
42. 2 receptors in rat substantia nigra neurones. J. Physiol. (Lond.), 401: 437-453.
43. Law, P.Y., Hom, D.S. and Loh, H.H. (1982) Loss of opiate receptor activity in neuroblastoma x glioma NG108-15 hybrid cells after chronic opiate treatment. Mol. Pharmacol., 22: 1-4.
44. Levine, J.D. and Taiwo, Y.O. (1989) Involvement of the mu-opiate receptor in peripheral analgesia. Neuroscience, 32: 571-575.
45. Lewis, V.A. and Gebhart, G.F. (1977) Evaluation of the periaqueductal central gray (PAG) as a morphine-specific locus of action and examination of morphine-induced and stimulation- produced analgesia at coincident PAG loci. Brain Res., 124: 283-303.
46. Li, L.-Y. and Chang, K.-J. (1996) The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express μ-opioid receptors. Mol. Pharmacol., 50: 599-602.
47. Malmberg, A. (2000) Protein kinase subtypes involved in injury-induced nociception. In: J. Sandkühler, B. Bromm and G.F. Gebhart (Eds.), Nervous System Plasticity and Chronic Pain. Progress in Brain Research, Vol. 129. Elsevier, Amsterdam, pp. 51-59.
48. Malmberg, A.B. and Yaksh, T.L. (1993) Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology, 79: 270-281.
49. Manzoni, O.J. and Williams, J.T. (1999) Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J. Neurosci., 19: 6629-6636.
50. Maves, T.J., Pechman, P.S., Meller, S.T. and Gebhart, G.F. (1994) Ketorolac potentiates morphine antinociception during visceral nociception in the rat. Anesthesiology, 80: 1094-1101.
51. Mayer, D.J. and Liebeskind, J.C. (1974) Pain reduction by focal electrical stimulation of the brain: An anatomical and behavioral analysis. Brain Res., 68: 73-93.
52. McCormack, K. (1994) Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain, 59: 9-43.
53. Millan, M.J., Morris, B.J., Colpaert, F.C. and Herz, A. (1987) A model of chronic pain in the rat: High-resolution neuroanatomical approach identifies alterations in multiple opioid systems in the periaqueductal grey. Brain Res., 416: 349-353.
54. Moreau, J.L. and Fields, H.L. (1986) Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission. Brain Res., 397: 37-46.
55. Morgan, M.M., Heinricher, M.M. and Fields, H.L. (1992) Circuitry linking opioid-sensitive nociceptive modulatory systems in periaqueductal gray and spinal cord with rostral ventromedial medulla. Neuroscience, 47: 863-871.
56. Nestler, E.J. and Tallman, J.F. (1987) Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol., 33: 127-132.
57. Nicoll, R.A., Alger, B.E. and Jahr, C.E. (1980) Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature, 287: 22-25.
58. Noble, F. and Cox, B.M. (1996) Differential desensitization of μ- and δ-opioid receptors in selected neural pathways following chronic morphine treatment. Br. J. Pharmacol., 117: 161-169.
59. Osborne, P.B., Vaughan, C.W., Wilson, H.I. and Christie, M.J. (1996) Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro. J. Physiol. (Lond.), 490: 383-389.
60. Pertovaara, A. (2000) Plasticity in descending pain modulatory systems. In: J. Sandkühler, B. Bromm and G.F. Gebhart (Eds.), Nervous System Plasticity and Chronic Pain. Progress in Brain Research, Vol. 129. Elsevier, Amsterdam, pp. 231-242.
61. Reichling, D.B. and Basbaum, A.I. (1990) Contribution of brainstem GABAergic circuitry to descending antinociceptive controls, II. Electron microscopic immunocytochemical evidence of GABAergic control over the projection from periaqueductal gray to the nucleus raphe magnus in the rat. J. Comp. Neurol., 302: 378-393.
62. Savage, S.R. (1999) Opioid use in the management of chronic pain. Med. Clin. North Am., 83: 761-786.
63. 2+ currents, but spares a sustained current. Neuron, 6: 13-20.
64. Sharma, S.K., Klee, W.A. and Nirenberg, M. (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA, 72: 3092-3096.
65. Sharma, S.K., Klee, W.A. and Nirenberg, M. (1977) Opiate-dependent modulation of adenylate cyclase. Proc. Natl. Acad. Sci. USA, 74: 3365-3369.
66. Sutherland, S.P., Cook, S.P. and McCleskey, E.W. (2000) Chemical mediators of pain due to tissue damage and ischemia. In: J. Sandkühler, B. Bromm and G.F. Gebhart (Eds.), Nervous System Plasticity and Chronic Pain. Progress in Brain Research, Vol. 129. Elsevier, Amsterdam, pp. 21-38.
67. Tortorici, V. and Vanegas, H. (1995) Anti-nociception induced by systemic or PAG-microinjected lysine-acetylsalicylate in rats. Effects on tail-flick related activity of medullary off- and on-cells. Eur. J. Neurosci., 7: 1857-1865.
68. Tortorici, V., Vásquez, E. and Vanegas, H. (1996) Naloxone partial reversal of the antinociception produced by dipyrone microinjected into the periaqueductal gray of rats. Possible involvement of medullary off- and on-cells. Brain Res., 725: 106-110.
69. Urban, M.O. and Gebhart, G.F. (1999) Central mechanisms in pain. Med. Clin. North Am., 83: 585-596.
70. Vaughan, C.W. (1998) Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones. Br. J. Pharmacol., 123: 1479-1481.
71. Vaughan, C.W., Ingram, S.L., Connor, M.A. and Christie, M.J. (1997) How opioids inhibit GABA-mediated neurotransmission. Nature, 390: 611-614.
72. Wang, Q.-P., Guan, J.-L. and Nakai, Y. (1994) Immunoelectron microscopy of enkephalinergic innervation of GABAergic neurons in the periaqueductal gray. Brain Res., 665: 39-46.
73. Williams, F.G., Mullet, M.A. and Beitz, A.J. (1995) Basal release of Met-enkephalin and neurotensin in the ventrolateral periaqueductal gray matter of the rat: A microdialysis study of antinociceptive circuits. Brain Res., 690: 207-216.
74. Williams, J.T., Egan, T.M. and North, R.A. (1982) Enkephalin opens potassium channels on mammalian central neurones. Nature, 299: 74-77.
75. Wimpey, T.L. and Chavkin, C. (1991) Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation. Neuron, 6: 281-289.
76. Yaksh, T.L., Yeung, J.C. and Rudy, T.A. (1976) Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray. Brain Res., 114: 83-103.
77. Zambotti, F., Zonta, N., Parenti, M., Tommasi, R., Vicentini, L., Conci, F. and Mantegazza, P. (1982) Periaqueductal gray matter involvement in the muscimol-induced decrease of morphine antinociception. Naunyn-Schmiedebergs Arch. Pharmacol., 318: 368-369.